Managing access to advanced therapy medicinal products: Challenges for NHS Wales

This viewpoint reflects on the experience of introducing these advanced therapy medicinal products into the NHS in Wales, where £1 in every £200 spent on medicines (2019/2020) is expected to be on them for just 20 patients.


British Journal of Clinical Pharmacology